Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 6/20 | 0.59 |
| ▸ | CA1 | P00915 | 4/20 | 0.59 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.50 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ATM | Q13315 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.36 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.36 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.36 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6172244 | 0.94 | ZDHHC7 (0.58) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL10487617 | 0.92 | ZDHHC7 (0.61) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL11725954 | 0.92 | ZDHHC7 (0.61) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL668999 | 0.92 | ZDHHC7 (0.61) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL16059319 | 0.87 | CA2 (0.59) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL4431247 | 0.86 | CA1 (0.47) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL27611789 | 0.85 | CA2 (0.47) | CA2CA1ZDHHC7TSHRCYP3A4 | |
| SCHEMBL27725954 | 0.83 | CA2 (0.46) | CA2CA1ZDHHC7TSHRCYP3A4 | |
| SCHEMBL27437393 | 0.83 | CA2 (0.46) | CA2CA1ZDHHC7TSHRCYP3A4 | |
| SCHEMBL27341188 | 0.83 | CA2 (0.46) | CA2CA1ZDHHC7TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388780-A1 | WATER-DISPERSIBLE RESIN PARTICLE, WATER-BORNE COATING COMPOSITION, COATED ARTICLE, AND PRODUCTION METHODS THEREFOR | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2025-12-25 | — | — | US | disclosed |
| EP-4553118-A1 | WATER-DISPERSIBLE RESIN PARTICLE, AQUEOUS COATING COMPOSITION, COATED ARTICLE, AND PRODUCTION METHODS THEREFOR | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2025-05-14 | — | — | EP | disclosed |
| US-11247231-B2 | Method for forming multilayer coating film | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2022-02-15 | — | — | US | disclosed |
| US-20210245198-A1 | METHOD FOR FORMING MULTILAYER COATING FILM | NIPPON PAINT AUTOMOTIVE COATINGS CO., LTD. (JP) | 2021-08-12 | — | — | US | disclosed |
| EP-3827904-A1 | MULTILAYER COATING FILM FORMING METHOD | Nippon Paint Automotive Coatings Co., Ltd. (JP) | 2021-06-02 | — | — | EP | disclosed |
| EP-1778804-A1 | SINGLE-COMPONENT SYSTEM BASED ON CO-REACTIVE LATEX, PREPARATION METHOD AND USE IN THE FIELD OF FORMOL-FREE COATINGS | Arkema France (FR) | 2007-05-02 | — | — | EP | disclosed |
| WO-2006010804-A1 | SINGLE-COMPONENT SYSTEM BASED ON CO-REACTIVE LATEX, PREPARATION METHOD AND USE IN THE FIELD OF FORMOL-FREE COATINGS | ARKEMA FRANCE (FR) | 2006-02-02 | — | — | WO | disclosed |
| WO-2005123724-A1 | 2,4-DIAMINOQUINAZOLINES FOR SPINAL MUSCULAR ATROPHY | DECODE CHEMISTRY, INC. (US) | 2005-12-29 | — | — | WO | disclosed |
| EP-0652749-A4 | METHODS AND COMPOSITIONS FOR INHIBITING 5-g(a)-REDUCTASE ACTIVITY. | ARCH DEV CORP (US) | 1997-04-09 | — | — | EP | disclosed |
| US-5453534-A | Preparation of alkoxycarboxylic acid esters | BASF AKTIENGESELLSCHAFT (DE) | 1995-09-26 | — | — | US | disclosed |
| EP-0652749-A1 | METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY | ARCH DEVELOPMENT CORPORATION (US) | 1995-05-17 | — | — | EP | disclosed |
| WO-1994001100-A1 | METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY | ARCH DEVELOPMENT CORPORATION (US) | 1994-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388780-A1 | WATER-DISPERSIBLE RESIN PARTICLE, WATER-BORNE COATING COMPOSITION, COATED ARTICLE, AND PRODUCTION METHODS THEREFOR | CDH1, CAD, ITGA1 | CA2 2413/4885CA1 800/4885ZDHHC7 4025/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.